Australian Pharmaceuticals & Biotech Pure Equity Growth

Results

0 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

2 companies

Neuren Pharmaceuticals

Market Cap: AU$2.2b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$17.51

4.4%

18.0%

Neuren Pharmaceuticals

Market Cap: AU$2.2b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$17.38

3.3%

17.0%